Javier Andres Villafuerte Galvez, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Clostridium Infections | 10 | 2024 | 557 | 2.340 |
Why?
|
Celiac Disease | 8 | 2024 | 819 | 1.970 |
Why?
|
Enterocolitis, Pseudomembranous | 3 | 2021 | 264 | 1.650 |
Why?
|
Diet, Gluten-Free | 6 | 2022 | 283 | 0.890 |
Why?
|
Diarrhea | 3 | 2023 | 1317 | 0.810 |
Why?
|
Drug Repositioning | 1 | 2024 | 233 | 0.810 |
Why?
|
Feces | 6 | 2023 | 1490 | 0.750 |
Why?
|
Bacterial Toxins | 5 | 2023 | 925 | 0.620 |
Why?
|
Interleukin-1beta | 1 | 2023 | 998 | 0.560 |
Why?
|
Proton Pump Inhibitors | 2 | 2021 | 533 | 0.540 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1810 | 0.480 |
Why?
|
Colitis, Lymphocytic | 1 | 2012 | 23 | 0.410 |
Why?
|
Enterotoxins | 3 | 2023 | 366 | 0.370 |
Why?
|
Secondary Prevention | 1 | 2017 | 1470 | 0.360 |
Why?
|
Anti-Bacterial Agents | 6 | 2024 | 7403 | 0.340 |
Why?
|
Parasitic Diseases | 1 | 2008 | 76 | 0.310 |
Why?
|
PubMed | 1 | 2009 | 129 | 0.300 |
Why?
|
Tropical Medicine | 1 | 2008 | 51 | 0.300 |
Why?
|
Antibodies, Neutralizing | 1 | 2017 | 1936 | 0.290 |
Why?
|
Peru | 5 | 2012 | 890 | 0.280 |
Why?
|
Journalism, Medical | 1 | 2007 | 73 | 0.270 |
Why?
|
Colon | 2 | 2018 | 1791 | 0.260 |
Why?
|
Glutens | 2 | 2020 | 240 | 0.250 |
Why?
|
Patient Compliance | 1 | 2015 | 2688 | 0.240 |
Why?
|
Amoxicillin | 2 | 2016 | 181 | 0.230 |
Why?
|
Access to Information | 1 | 2007 | 316 | 0.230 |
Why?
|
Information Storage and Retrieval | 1 | 2009 | 819 | 0.210 |
Why?
|
Antitoxins | 1 | 2023 | 77 | 0.210 |
Why?
|
Gastroenterology | 1 | 2009 | 580 | 0.200 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3031 | 0.190 |
Why?
|
Health Education | 1 | 2007 | 1049 | 0.180 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9171 | 0.170 |
Why?
|
Habits | 1 | 2020 | 147 | 0.170 |
Why?
|
Immunoglobulin A | 1 | 2023 | 978 | 0.160 |
Why?
|
Recurrence | 4 | 2022 | 8426 | 0.160 |
Why?
|
Periodicals as Topic | 1 | 2009 | 1463 | 0.150 |
Why?
|
Clavulanic Acid | 1 | 2016 | 19 | 0.140 |
Why?
|
Carrier State | 1 | 2021 | 522 | 0.140 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 391 | 0.140 |
Why?
|
Pregnant Women | 1 | 2020 | 567 | 0.130 |
Why?
|
Metronidazole | 1 | 2016 | 232 | 0.120 |
Why?
|
Economic Competition | 1 | 2017 | 219 | 0.120 |
Why?
|
Students, Medical | 1 | 2008 | 1936 | 0.120 |
Why?
|
Capillary Permeability | 1 | 2018 | 773 | 0.120 |
Why?
|
Virulence Factors | 1 | 2018 | 513 | 0.120 |
Why?
|
Trametes | 1 | 2014 | 2 | 0.120 |
Why?
|
Education, Medical, Graduate | 1 | 2007 | 2373 | 0.120 |
Why?
|
Humans | 29 | 2024 | 760740 | 0.120 |
Why?
|
Prebiotics | 1 | 2014 | 41 | 0.120 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 414 | 0.110 |
Why?
|
Curriculum | 1 | 2007 | 3739 | 0.110 |
Why?
|
Vancomycin | 1 | 2016 | 503 | 0.110 |
Why?
|
Anemia | 1 | 2022 | 1504 | 0.110 |
Why?
|
Probiotics | 1 | 2016 | 378 | 0.100 |
Why?
|
Alanine Transaminase | 1 | 2015 | 601 | 0.100 |
Why?
|
Gastrointestinal Tract | 2 | 2016 | 834 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.100 |
Why?
|
Self Efficacy | 1 | 2015 | 636 | 0.090 |
Why?
|
Proteoglycans | 1 | 2014 | 803 | 0.090 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7050 | 0.090 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4533 | 0.090 |
Why?
|
School Admission Criteria | 1 | 2010 | 107 | 0.080 |
Why?
|
Tropical Climate | 1 | 2008 | 35 | 0.080 |
Why?
|
Bacterial Proteins | 2 | 2022 | 3842 | 0.080 |
Why?
|
Triage | 1 | 2015 | 984 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2018 | 3492 | 0.070 |
Why?
|
Incidence | 2 | 2018 | 21339 | 0.070 |
Why?
|
Irritable Bowel Syndrome | 1 | 2012 | 452 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2218 | 0.070 |
Why?
|
Biopsy | 2 | 2021 | 6763 | 0.070 |
Why?
|
Food Hypersensitivity | 1 | 2014 | 726 | 0.070 |
Why?
|
Parasites | 1 | 2008 | 160 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2192 | 0.060 |
Why?
|
Colonoscopy | 1 | 2012 | 1397 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 1999 | 0.060 |
Why?
|
Malpractice | 1 | 2008 | 556 | 0.060 |
Why?
|
Publishing | 1 | 2010 | 832 | 0.050 |
Why?
|
Ribotyping | 1 | 2022 | 35 | 0.050 |
Why?
|
Female | 14 | 2022 | 392203 | 0.050 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2022 | 141 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1921 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5493 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7805 | 0.050 |
Why?
|
Middle Aged | 10 | 2021 | 220603 | 0.050 |
Why?
|
Adult | 10 | 2022 | 220995 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10203 | 0.050 |
Why?
|
Prospective Studies | 4 | 2022 | 54364 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4010 | 0.040 |
Why?
|
Health Services Research | 1 | 2007 | 1808 | 0.040 |
Why?
|
Micronutrients | 1 | 2022 | 381 | 0.040 |
Why?
|
Teaching | 1 | 2007 | 1169 | 0.040 |
Why?
|
Immunoenzyme Techniques | 1 | 2022 | 1703 | 0.040 |
Why?
|
North America | 1 | 2022 | 1273 | 0.040 |
Why?
|
Male | 12 | 2022 | 360402 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 29869 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 487 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2018 | 193 | 0.040 |
Why?
|
Antibodies, Bacterial | 1 | 2022 | 1464 | 0.030 |
Why?
|
Folic Acid | 1 | 2022 | 1323 | 0.030 |
Why?
|
Poverty | 1 | 2007 | 2692 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2015 | 7873 | 0.030 |
Why?
|
Risk Factors | 3 | 2018 | 74128 | 0.030 |
Why?
|
Aged | 4 | 2016 | 169092 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2047 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2019 | 637 | 0.030 |
Why?
|
Epithelium | 1 | 2018 | 1603 | 0.030 |
Why?
|
Animals | 3 | 2018 | 168202 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 524 | 0.030 |
Why?
|
HLA-DQ Antigens | 1 | 2014 | 190 | 0.030 |
Why?
|
Research Design | 1 | 2008 | 6174 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12966 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9461 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20556 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 414 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2021 | 1927 | 0.020 |
Why?
|
Medical Records | 1 | 2016 | 1408 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 991 | 0.020 |
Why?
|
Inpatients | 1 | 2022 | 2545 | 0.020 |
Why?
|
Metagenomics | 1 | 2014 | 463 | 0.020 |
Why?
|
Internship and Residency | 1 | 2010 | 5878 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2506 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12143 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2018 | 2644 | 0.020 |
Why?
|
Colitis | 1 | 2016 | 1234 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2015 | 1725 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8516 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6305 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2016 | 80583 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7512 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10072 | 0.020 |
Why?
|
Young Adult | 3 | 2016 | 59191 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3567 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 64572 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39062 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13248 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8835 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 12934 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10549 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15250 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6390 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22153 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18381 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15702 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23415 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14024 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81368 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 88247 | 0.000 |
Why?
|
United States | 1 | 2015 | 72292 | 0.000 |
Why?
|